Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer

被引：0
|
作者：
Streckert, I [1 ]
Bonatz, G. [2 ]
Kucharski, K. [3 ]
Marek, W.
Streckert, H. J.
Phillipou, S.
机构：
[1] Augusta Krankenanstalten, Inst Pathol & Zytol, Inst Pathol, Bochum, Germany
[2] Augusta Krankenanstalten, Bochum, Germany
[3] Malteser Krankenhaus St Anna, Brustzentrum Duisburg, Duisburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2008年 / 68卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [1] Study on the prognostic impact of uPA and PAI-1 for nodal negative invasive breast cancer
    Streckert, I.
    Bonatz, G.
    Kucharski, K.
    Marek, W.
    Streckert, H.-J.
    Philippou, S.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 303 - 304
  • [2] Prognostic significance of uPA and PAI-1 in relation to other prognosticators for the clinical outcome of breast cancer
    Knoop, AS
    Laenkholm, AV
    Hansen, S
    Andersen, J
    Andreasen, PA
    Anderson, JA
    Overgaard, J
    Rose, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 648 - 648
  • [3] Prognostic importance of the uPA/PAI-1 complex in breast cancer
    Sten-Linder, M
    Seddighzadeh, M
    Engel, G
    Rutqvist, LE
    Linder, S
    Skoog, L
    Wiman, B
    ANTICANCER RESEARCH, 2001, 21 (4B) : 2861 - 2865
  • [4] Prognostic significance of urokinase plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer
    Vrbanec, D.
    Jelisavac-Cosic, S.
    Jakic-Razumovic, J.
    Mustac, E.
    Kuzmic-Prusac, I.
    EJC SUPPLEMENTS, 2004, 2 (03): : 180 - 181
  • [5] Prognostic and predictive impact of uPA/PAI-1 in early breast cancer
    Wieder, V.
    Engel, J.
    Bauer, M.
    Kaufhold, S.
    Hanf, V.
    Uleer, C.
    Lantzsch, T.
    Peschel, S.
    John, J.
    Poehler, M.
    Weigert, E.
    Burrig, K-F.
    Buchmann, J.
    Kantelhardt, E.
    Thomssen, C.
    Vetter, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S297 - S297
  • [6] The value of uPA and PAI-1 levels in triple negative breast cancer
    Sobocan, M.
    Ledinek, Z.
    Crnobrnja, B.
    Sikosek, N. Cas
    Dovnik, N. Fokter
    Kavalar, R.
    Knez, J.
    Takac, I.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S73 - S74
  • [7] Innovation-Implementation and Quality-Gain through Care Management by Health Insurers by reference to the Biomarkers uPA/PAI-1 in nodal-negative Breast Cancer
    Jacobs, V. R.
    Kapitza, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2012, 72 (07) : P4 - P4
  • [8] Role of uPA and PAI-1 mRNA expression as prognostic factors in molecular subtypes of breast cancer
    Witzel, I.
    Milde-Langosch, K.
    Schmidt, M.
    Karn, T.
    Rody, A.
    Wirtz, R.
    Jaenicke, F.
    Mueller, V.
    CANCER RESEARCH, 2013, 73
  • [9] uPA and PAI-1: Clinically and technically validated prognostic markers in breast cancer
    Duffy, M. J.
    EJC SUPPLEMENTS, 2006, 4 (06): : 7 - 7
  • [10] EVALUATION OF UPA/PAI-1 AS A PROGNOSTIC MARKER IN YOUNG WOMEN WITH BREAST CANCER
    Sobocan, M.
    Dimnik, U.
    Dezman, B.
    Turk, M.
    Kavalar, R.
    Takac, I.
    Arko, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A154 - A154
12345